Effect of behavioral interventions on insulin sensitivity and atherosclerosis in the Watanabe heritable hyperlipidemic rabbit

Psychosomatic Medicine

Volumn 67, Issue 2, 2005, Pages 172-178

  Gonzales, Julie A ^a   Szeto, Angela ^a   Mendez, Armando J ^b   Zaias, Julia ^c   Paredes, Jamespaul ^a   Caperton, Caroline V ^a   Llabre, Maria M ^a   Levine, Jon E ^d   Goldberg, Ronald B ^b   Schneiderman, Neil ^a   McCabe, Philip M ^a  

^a Department of Biology   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Diet; Exercise; Insulin resistance; WHHL rabbit

Indexed keywords

GLUCOSE; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BEHAVIOR; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIET; DIET RESTRICTION; DISEASE COURSE; DYSLIPIDEMIA; EXERCISE; GLUCOSE TOLERANCE TEST; HYPERLIPIDEMIA; INSULIN METABOLISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

AGE FACTORS; ANIMALS; AORTA; AORTIC DISEASES; ATHEROSCLEROSIS; BEHAVIOR, ANIMAL; BLOOD GLUCOSE; BODY WEIGHT; DIET; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEEDING BEHAVIOR; GLUCOSE TOLERANCE TEST; HYPERLIPIDEMIAS; INSULIN; INSULIN RESISTANCE; MALE; PHYSICAL CONDITIONING, ANIMAL; RABBITS;

EID: 20144385740     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.psy.0000155674.95497.ab     Document Type: Article

References (26)

1. Buja LM, Kita T, Goldstein JL, Watanabe Y, Brown MS. Cellular pathology of progressive atherosclerosis in the WHHL rabbit. Arteriosclerosis 1983;3:87-101.
2. McCabe PM, Gonzales JA, Zaias J, Szeto A, Kumar M, Herron AJ, Schneiderman N. Social environment influences the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Circulation 2002;105:354-9.
3. Zhang Saku K, Hirata K, Liu R, Tateishi K, Yamamoto K, Arakawa K. Insulin resistance observed in WHHL rabbits. Athersclerosis 1991;91:277-8.
4. Zhang Saku K, Hirata K, Liu R, Tateishi K, Shiomi M, Arakawa K. Quantitative characterization of insulin-glucose response in Watanabe heritable hyperlipidemic and cholesterol-fed rabbits and the effect of cilazapril. Metabolism 1994;43:360-6.
5. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-94.
6. Hsueh WA, Lyon CJ, Quinones MJ. Insulin resistance and the endothelium. Am J Med 2004;117:109-17.
7. Schneiderman N, Skyler JS. Insulin metabolism, sympathetic nervous system regulation, and coronary heart disease prevention. In: Orth-Gomer K, Schneiderman N, eds. Behavioral Medicine Approaches to Cardiovascular Disease Prevention. Mahwah, NJ: Erlbaum; 1996:105-33.
8. The Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
9. DiCarlo SE, Bishop VS. Exercise training attenuates baroreflex regulation of nerve activity in rabbits. Am J Physiol 1988;255:H974-9.
10. Brooks D. Nutrition and gastrointestinal physiology. In: Hillyer EV, Quesenberry, KE, eds. Ferrets, Rabbits, and Rodents: Clinical Medicine and Surgery. Philadelphia: WB Saunders Co; 1997:169-75.
11. Szeto A, Gonzales JA, Spitzer SB, Levine JE, Zaias J, Saab PG, Scheiderman N, McCabe PM. Circulating levels of glucocorticoid hormones in WHHL and NZW rabbits: circadian cycle and response to repeated social encounter. Psychoneuroendocrinology 2004;29:861-6.
12. Bergman RN. Toward physiological understanding of glucose tolerance: minimal model approach. Diabetes 1989;38:1512-27.
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
14. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 2000;23:57-63.
15. Haymond MW. Measuring insulin resistance: a task worth doing. But how? Ped Diab 2003;4:115-8.
16. Howard G, Bergman R, Wagenknecht LE, Haffner SM, Savage PJ, Saad MF, Laws A, D'Agostino RB. Ability of alternative indices of insulin sensitivity to predict cardiovascular risk: comparison with the 'minimal model.' Ann Epidemiol 1998;8:358-69.
17. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol 1993;137:959-65.
18. McAuley KA, Williams SM, Mann JI, Walker RJ, Lewis-Barned NJ, Temple LA, Duncan AW. Diagnosing insulin resistance in the general population. Diabetes Care 2001;24:460-4.
19. Kaplan JR, Manuck SB. Antiatherogenic effects of β-adrenergic blocking agents: theoretical, experimental, and epidemiologic considerations. Am Heart J 1994;128:1316-28.
20. Heiman ML, Ahima RS, Craft LS, Schoner B, Stephens TW, Flier JS. Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinologist 1997;138:3859-63.
21. Dantzer R. Cytokine-induced sickness behavior: where do we stand? Brain Behav Immun 2001;15:7-24.
22. Lacombe C, Corraze G, Nibbelink M. Increases in hyperlipoproteinemia, disturbances in cholesterol metabolism and atherosclerosis induced by dietary restriction in rabbits fed a cholesterol-rich diet. Lipids 1983;18:306-12.
23. Lacombe C, Corraze G. Effect of dietary restriction on receptor-mediated and independent catabolism of β-very low density lipoproteins in cholesterol-fed rabbits. J Nutr 1989;119:1513-8.
24. Dimsdale JE, Moss J. Plasma catecholamines in stress and exercise. JAMA 1980;243:340-2.
25. Williams JK, Kaplan JR, Suparto IH, Fox JL, Manuck SB. Effects of exercise on cardiovascular outcomes in monkeys with risk factors for coronary heart disease. Arterioscler Thromb Vasc Biol 2003;23:864-71.
26. Shiomi M, Ito T, Tsukada T, Tsujita Y, Horikoshi H. Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows a synergistic effect on atherosclerosis of WHHL rabbits. Atherosclerosis 1999;142:345-53.